John Radford

The University of Manchester

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Imaging Medical Imaging professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

ANASTASIOS STATHIS

Head of Research Service and Scientific Head Clinical Trial Unit

Istituto Cantonale di Patologia

SWITZERLAND

View details

Sally Barrington

King’s College London

UNITED KINGDOM

View details

Iain Macpherson

Professor of Breast Oncology

UNITED KINGDOM

View details

Isildinha Reis

University of Miami Health System

UNITED STATES

View details

Alexander Fletcher

Clinical Lecturer in Child Health

University of Glasgow

UNITED KINGDOM

View details

Francine Foss

UNITED STATES

View details

francesco damore

Professor

Aarhus University Hospital

DENMARK

View details

Swaminathan P. Iyer

Professor of Medicine

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Daniel Molin

Associate Professor

Uppsala University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Radford

Research Interests

Explore related searches

Contact this professor

Articles (17)

Clinical Outcomes of Older and Younger Patients Treated with Loncastuximab Tesirine in the LOTIS-2 Clinical Trial

PET/CT-biomarkers enable risk stratification of patients with relapsed/refractory diffuse large B-cell lymphoma enrolled in the LOTIS-2 clinical trial

Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial

The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network

Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions

Use of a real-world synthetic control arm for direct comparison of lisocabtagene maraleucel and conventional therapy in relapsed/refractory large B-cell lymphoma

A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma

The iR2 regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL

Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma

Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity

Pilot study of lung cancer screening for survivors of Hodgkin lymphoma

Five-year follow-up of KEYNOTE-087

Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma

Brentuximab Vedotin in Advanced Hodgkin’s Lymphoma

Treatment patterns and outcomes in relapsed/refractory follicular lymphoma

Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma

Collaborators (9)

ANASTASIOS STATHIS

Sally Barrington

Iain Macpherson

Isildinha Reis

Alexander Fletcher

Francine Foss

francesco damore

Swaminathan P. Iyer

Daniel Molin

Make your next move.